Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

POAI Predictive Oncology Inc

-0.02 (-1.71%)
Pre Market
Last Updated: 08:55:52
Delayed by 15 minutes


Draw Mode:

Volume 788
Bid Price 1.17
Ask Price 1.23
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Predictive Oncology Inc POAI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.71% 1.15 08:55:52
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
13 788 - 1.12 - 7.12
Last Trade Time Type Quantity Stock Price Currency
08:28:19 1 $ 1.23 USD

Predictive Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.75M 4.06M - 1.78M -13.98M -3.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Predictive Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No POAI Message Board. Create One! See More Posts on POAI Message Board See More Message Board Posts

Historical POAI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.211.381.161.2878,700-0.06-4.96%
1 Month1.702.591.152.065,363,142-0.55-32.35%
3 Months2.652.811.122.021,932,578-1.50-56.60%
6 Months3.193.761.122.04908,558-2.04-63.95%
1 Year3.807.121.122.19480,233-2.65-69.74%
3 Years20.4029.3241.1213.27805,352-19.25-94.36%
5 Years13.998107.801.1220.761,016,815-12.85-91.78%

Predictive Oncology Description

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.

Your Recent History

Delayed Upgrade Clock